Insiders · SLN

David Lemus

Director at Silence Therapeutics plc (SLN) since January 2025

David Lemus has filed 8 insider reports with the SEC since August 2021, as director at Silence Therapeutics plc (SLN), director at Scilex Holding Co (SCLX) and director at Sorrento Therapeutics, Inc. (SRNE). David Lemus made no open-market purchases or sales in the last 12 months. The latest filing, on January 6, 2026, reports grant or award at Silence Therapeutics plc (SLN).

Filings
8
Companies
3
Bought on market
$1,800
Sold on market
None

Companies where David Lemus is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Silence Therapeutics plc logo
SLN
Silence Therapeutics plc
Directorsince January 20257,527$19.81Jan 6, 2026
Scilex Holding Co logo
SCLX
Scilex Holding Co
Directorsince November 20222,000$1,800$0.90$0.5658-37%Oct 18, 2024
Sorrento Therapeutics, Inc. logo
SRNE
Sorrento Therapeutics, Inc.
DirectorAug 31, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with David Lemus.

Compare David Lemus with

Other insiders at the same companies

Questions about David Lemus

What is David Lemus's role at Silence Therapeutics plc?
David Lemus reports to the SEC as director at Silence Therapeutics plc (SLN), according to the latest filing on January 6, 2026. David Lemus has also filed as director at Scilex Holding Co (SCLX) and director at Sorrento Therapeutics, Inc. (SRNE).
How many shares does David Lemus own?
After the latest filing that states it, David Lemus directly owned 7,527 shares of Silence Therapeutics plc (SLN) and 2,000 shares of Scilex Holding Co (SCLX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has David Lemus bought or sold stock recently?
The most recent open-market purchase was on October 17, 2024: bought 2,000 shares of Scilex Holding Co (SCLX) for $1,800 at an average of $0.90.
How do I get alerts when David Lemus files?
Follow David Lemus on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David Lemus (SEC CIK 0001717972). Totals count each trade once, skipping amendments whose original is on file, from Aug 31, 2021 on. View on SEC EDGAR · Get this as JSON